Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galnobax for Diabetic Foot Ulcers
NCT03998436Phase 3Completed
- Sponsor
- NovaLead Pharma
- Start
- Dec 2018
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of esmolol in diabetic foot ulcer (DFU), sponsored by NovaLead Pharma. Started Dec 2018; status: completed.
02
Drugs
esmolol
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03998436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998436.